Caffeine drinking potentiates cannabinoid transmission in the striatum: Interaction with stress effects

Neuropharmacology

Volumn 56, Issue 3, 2009, Pages 590-597

  Rossi, Silvia ^a,b   De Chiara, Valentina ^a,b   Musella, Alessandra ^a,b   Mataluni, Giorgia ^a,b   Sacchetti, Lucia ^c   Siracusano, Alberto ^c   Bernardi, Giorgio ^a,b   Usiello, Alessandro ^d,e   Centonze, Diego ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^e UNIVERSITY OF MOLISE   (Italy)

Author keywords

Basal ganglia; EPSC; IPSC; mGlu 5 receptors; Reward

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; BACLOFEN; BICUCULLINE; CAFFEINE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; DEXANABINOL; DIZOCILPINE; ENDOCANNABINOID; GLUTAMIC ACID; PSYCHOTROPIC AGENT; SODIUM CHLORIDE; TETRODOTOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEVERAGE; COFFEE; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; GABAERGIC SYSTEM; LIFE EVENT; MALE; MOUSE; NONHUMAN; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; SINGLE DRUG DOSE; SOCIAL STRESS; STRESS; SYNAPTIC TRANSMISSION;

ANIMALS; CAFFEINE; CORPUS STRIATUM; GLUTAMIC ACID; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION; RECEPTOR, CANNABINOID, CB1; STRESS, PSYCHOLOGICAL; SYNAPTIC TRANSMISSION;

EID: 58749101154     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.10.013     Document Type: Article

References (54)

1. Acquas E., Tanda G., and Di Chiara G. Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats. Neuropsychopharmacology 27 (2002) 182-193
2. Anggadiredja K., Nakamichi M., Hiranita T., Tanaka H., Shoyama Y., Watanabe S., and Yamamoto T. Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade. Neuropsychopharmacology 29 (2004) 1470-1478
3. Avgustinovich D.F., Kovalenko I.L., and Koryakina L.A. A model of anxious depression: persistence of behavioral pathology. Neuroscience and Behavioral Physiology 35 (2005) 917-924
4. Bedingfield J.B., King D.A., and Holloway F.A. Cocaine and caffeine: conditioned place preference, locomotor activity, and additivity. Pharmacology Biochemistry and Behavior 61 (1998) 291-296
5. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., Graham D., Tsankova N.M., Bolanos C.A., Rios M., Monteggia L.M., Self D.W., and Nestler E.J. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311 (2006) 864-868
6. Borgkvist A., and Fisone G. Psychoactive drugs and regulation of the cAMP/PKA/DARPP-32 cascade in striatal medium spiny neurons. Neuroscience & Biobehavioral Reviews 31 (2007) 79-88
7. Calabresi P., Mercuri N.B., De Murtas M., and Bernardi G. Involvement of GABA systems in feedback regulation of glutamate-and GABA-mediated synaptic potentials in rat neostriatum. Journal of Physiology 440 (1991) 581-599
8. Cauli O., and Morelli M. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists. Psychopharmacology 162 (2002) 246-254
9. Celik E., Uzbay I.T., and Karakas S. Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice. Progress in Neuropsychopharmacology and Biological Psychiatry 30 (2006) 50-55
10. Centonze D., Battista N., Rossi S., Mercuri N.B., Finazzi-Agro A., Bernardi G., Calabresi P., and Maccarrone M. A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal GABAergic transmission. Neuropsychopharmacology 29 (2004) 1488-1497
11. Centonze D., Rossi S., De Chiara V., Prosperetti C., Battista N., Bernardi G., Mercuri N.B., Usiello A., and Maccarrone M. Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors. European Journal of Neuroscience 25 (2007) 1631-1640
12. Corbillé A.G., Valjent E., Marsicano G., Ledent C., Lutz B., Hervé D., and Girault J.A. Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants. Journal of Neuroscience 27 (2007) 6937-6947
13. Conney A.H., Zhou S., Lee M.J., Xie J.G., Yang C.S., Lou Y.R., and Lu Y. Stimulatory effect of oral administration of tea, coffee or caffeine on UVB-induced apoptosis in the epidermis of SKH-1 mice. Toxicology and Applied Pharmacology 224 (2007) 209-213
14. Cornelis M.C., El-Sohemy A., and Campos H. Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption. American Journal of Clinical Nutrition 86 (2007) 240-244
15. Dall'Igna O.P., Da Silva A.L., Dietrich M.O., Hoffmann A., de Oliveira R.V., Souza D.O., and Lara D.R. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-d-aspartate receptor antagonist MK-801 in mice. Psychopharmacology 166 (2003) 258-263
16. de Leon J., Diaz F.J., Rogers T., Browne D., Dinsmore L., Ghosheh O.H., Dwoskin L.P., and Crooks P.A. A pilot study of plasma caffeine concentrations in a US sample of smoker and nonsmoker volunteers. Progress in Neuropsychopharmacology and Biological Psychiatry 27 (2003) 165-171
17. De Vries T.J., Homberg J.R., Binnekade R., Raasø H., and Schoffelmeer A.N. Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology 168 (2003) 164-169
18. De Vries T.J., and Schoffelmeer A.N. Cannabinoid CB1 receptors control conditioned drug seeking. Trends in Pharmacological Sciences 26 (2005) 420-426
19. Economidou D., Mattioli L., Ubaldi M., Lourdusamy A., Soverchia L., Hardiman G., Campolongo P., Cuomo V., and Ciccocioppo R. Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol. Toxicology and Applied Pharmacology 223 (2007) 73-85
20. Finn I.B., and Holtzman S.G. Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity. Psychopharmacology 93 (1987) 428-434
21. Fisone G., Håkansson K., Borgkvist A., and Santini E. Signaling in the basal ganglia: postsynaptic and presynaptic mechanisms. Physiology and Behavior 92 (2007) 8-14
22. Fredholm B.B., Bättig K., Holmén J., Nehlig A., and Zvartau E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacological Reviews 51 (1999) 83-133
23. Freiman I., Anton A., Monyer H., Urbanski M.J., and Szabo B. Analysis of the effects of cannabinoids on identified synaptic connections in the caudate-putamen by paired recordings in transgenic mice. Journal of Physiology 575 (2006) 789-806
24. Gerdeman G., and Lovinger D.M. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. Journal of Neurophysiology 85 (2001) 468-471
25. Green T.A., and Schenk S. Dopaminergic mechanism for caffeine-produced cocaine seeking in rats. Neuropsychopharmacology 26 (2002) 422-430
26. Harris A., Ursin H., Murison R., and Eriksen H.R. Coffee, stress and cortisol in nursing staff. Psychoneuroendocrinology 32 (2007) 322-330
27. Herkenham M., Lynn A.B., de Costa B.R., and Richfield E.K. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Research 547 (1991) 267-274
28. Hnasko T.S., Sotak B.N., and Palmiter R.D. Morphine reward in dopamine-deficient mice. Nature 438 (2005) 854-857
29. Hohmann A.G., and Herkenham M. Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. Synapse 37 (2000) 71-80
30. Howell L.L. Comparative effects of caffeine and selective phosphodiesterase inhibitors on respiration and behavior in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics 266 (1993) 894-903
31. Huang C.C., Lo S.W., and Hsu K.S. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. Journal of Physiology 532 (2001) 731-748
32. Jung K.M., Mangieri R., Stapleton C., Kim J., Fegley D., Wallace M., Mackie K., and Piomelli D. Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Molecular Pharmacology 68 (2005) 1196-1202
33. Kawachi I., Willett W.C., Colditz G.A., Stampfer M.J., and Speizer F.E. A prospective study of coffee drinking and suicide in women. Archives of Internal Medicine 156 (1996) 521-525
34. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., Bohme G.A., Imperato A., Pedrazzini T., Roques B.P., Vassart G., Fratta W., and Parmentier M. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283 (1999) 401-404
35. Lopez F., Miller L.G., Greenblatt D.J., Kaplan G.B., and Shader R.I. Interaction of caffeine with the GABAA receptor complex: alterations in receptor function but not ligand binding. European Journal of Pharmacology 172 (1989) 453-459
36. Maccarrone M., Rossi S., Bari M., De Chiara V., Fezza F., Musella A., Gasperi V., Prosperetti C., Bernardi G., Finazzi-Agrò A., Cravatt B.F., and Centonze D. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nature Neuroscience 11 (2008) 152-159
37. Maldonado R., Valverde O., and Berrendero F. Involvement of the endocannabinoid system in drug addiction. Trends Neuroscience 29 (2006) 225-232
38. McGregor I.S., Dam K.D., Mallet P.E., and Gallate J.E. Delta9-THC reinstates beer- and sucrose-seeking behaviour in abstinent rats: comparison with midazolam, food deprivation and predator odour. Alcohol and Alcoholism 40 (2005) 35-45
39. Navarro M., Carrera M.R., Fratta W., Valverde O., Cossu G., Fattore L., Chowen J.A., Gomez R., del Arco I., Villanua M.A., Maldonado R., Koob G.F., and Rodriguez de Fonseca F. Functional interaction between opioid and cannabinoid receptors in drug self-administration. Journal of Neuroscience 21 (2001) 5344-5350
40. Nehlig A. Are we dependent upon coffee and caffeine? A review on human and animal data. Neuroscience & Biobehavioral Reviews 23 (1999) 563-576
41. Ogawa N., and Ueki H. Clinical importance of caffeine dependence and abuse. Psychiatry Clinical Neuroscience 61 (2007) 263-268
42. Piomelli D. The molecular logic of endocannabinoid signalling. Nature Reviews Neuroscience 4 (2003) 873-884
43. Rossi S., De Chiara V., Musella A., Kusayanagi H., Mataluni G., Bernardi G., Usiello A., and Centonze D. Chronic psychoemotional stress impairs cannabinoid receptor-mediated control of GABA transmission in the striatum. Journal of Neuroscience 28 (2008) 7284-7292
44. Satel S. Is caffeine addictive? - a review of the literature. American Journal of Drug and Alcohol Abuse 32 (2006) 493-502
45. Shoaib M. The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats. Neuropharmacology 54 (2008) 438-444
46. Steptoe A., Gibson E.L., Vuononvirta R., Williams E.D., Hamer M., Rycroft J.A., Erusalimsky J.D., and Wardle J. The effects of tea on psychophysiological stress responsivity and post-stress recovery: a randomised double-blind trial. Psychopharmacology 190 (2007) 81-89
47. Stern E.A., Jaeger D., and Wilson C.J. Membrane potential synchrony of simultaneously recorded striatal spiny neurons in vivo. Nature 394 (1998) 475-478
48. Svenningsson P., Nomikos G.G., and Fredholm B.B. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. Journal of Neuroscience 19 (1999) 4011-4022
49. Svikis D.S., Berger N., Haug N.A., and Griffiths R.R. Caffeine dependence in combination with a family history of alcoholism as a predictor of continued use of caffeine during pregnancy. American Journal of Psychiatry 162 (2005) 2344-2351
50. Szabo B., Dörner L., Pfreundtner C., Nörenberg W., and Starke K. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience 85 (1998) 395-403
51. Takeda E., Terao J., Nakaya Y., Miyamoto K., Baba Y., Chuman H., Kaji R., Ohmori T., and Rokutan K. Stress control and human nutrition. Journal of Medical Investigation 51 (2004) 139-145
52. Valjent E., Pagès C., Hervé D., Girault J.A., and Caboche J. Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. European Journal of Neuroscience 19 (2004) 1826-1836
53. Wang S.J. Caffeine facilitation of glutamate release from rat cerebral cortex nerve terminals (synaptosomes) through activation protein kinase C pathway: an interaction with presynaptic adenosine A1 receptors. Synapse 61 (2007) 401-411
54. Yamato T., Yamasaki S., Misumi Y., Kino M., Obata T., and Aomine M. Modulation of the stress response by coffee: an in vivo microdialysis study of hippocampal serotonin and dopamine levels in rat. Neuroscience Letters 332 (2002) 87-90